Lemanske RF, Mauger DT, Sorkness CA, et al, for the Childhood Asthma Research and Education (CARE) Network of the National, Heart, Lung, and Blood Institute. This study evaluated whether any of 3 ...
For patients with uncontrolled asthma despite the use of inhaled corticosteroids (ICS), common treatment options include addition of a long-acting beta agonist (LABA) and/or increasing the dose of ICS ...
At AANP 2026, clinicians share how NPs are on the front lines of asthma management, necessitating a full understanding of the ...
Please provide your email address to receive an email when new articles are posted on . Single-inhaler fluticasone furoate/umeclidinium/vilanterol triple therapy ...
Although epidemiologic studies involving U.S. patients with asthma show a greater burden in black patients than in whites, treatment recommendations are based on trials with few black participants.
Asthma is a chronic inflammatory condition marked by an imbalance in the immune response within the airways. According to Lancet, asthma affects around 339 million people globally. While conventional ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca’s fixed-dose triple-combination therapy BREZTRI Aerosphere® (budesonide/glycopyrrolate/formoterol fumarate or BGF ...
Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...
Please provide your email address to receive an email when new articles are posted on . Single maintenance and reliever therapy (SMART) had a lower total annual asthma management cost vs. traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results